Why can two laboratories report different deformulation results for the same product?
First check what the reports actually describe
Two deformulation reports carrying the same product name can describe different samples, different analytical scopes or different levels of claim. We compare those foundations before interpreting a changed ingredient list as proof that one report is wrong. The useful question is whether the reports make incompatible claims about the same material under comparable conditions, rather than whether their tables look identical. For the broader limits of a sample-based answer, see what deformulation can tell you.
The same product name is not the same sample state
Separate production batches can differ in composition, and different locations within a heterogeneous product can contain different balances of material. A concentrate, diluted product, dried film and cured article can share a product name while representing different concentration bases and chemical states. Storage aging can change small molecules through oxidation, migration or loss, so a retained specimen and a newly prepared specimen are not automatically equivalent.
Check the batch, preparation history, target layer and sampling position stated in each report before comparing names or estimated amounts. For example, a manufacturer comparing two primer reports may find that one describes the complete coated panel and the other the separated film. That difference can alter the metal and binder contributions without establishing an analytical contradiction.
Method scope changes what can be observed
A method directed toward extractable small molecules does not provide the same component coverage as a study also addressing polymer and inorganic fractions. Sample preparation can favor some ingredients over others, while signal overlap and low abundance can limit which components are resolved. An ingredient missing from one component table may therefore be outside the method scope, unresolved or below the relevant detection limit rather than confirmed absent.
Read the evidence and stated limitations to see which material classes were addressed and which were left outside the reported conclusion. An instrument list alone does not establish equal coverage, since preparation, measurement conditions and interpretation determine how the methods address the actual sample. Our method choices follow the sample and the agreed question, and the supporting data belong with the conclusion rather than replacing it.
Library coverage and standards affect naming
A spectral library can support a compound assignment when the measured features are distinctive and consistent with the proposed identity. Libraries differ in coverage, and related compounds can share features, so the nearest available match is not always a unique identification. Suitable reference standards can strengthen a comparison, but availability and the ability to distinguish relevant alternatives still matter. One report may therefore use a specific compound name while another stops at a chemical family because the evidence supports different naming confidence.
Separate identification from the amount claim
A chemical-family assignment is broader than identifying a specific compound, and an unresolved fraction is a third kind of statement rather than a missing ingredient by default. Compare the level of each claim before calling two labels contradictory: a specific member can be consistent with a broader family label. A semi-quantitative estimate and a calibrated quantitative result are also different claims, as explained in our identification and estimation guide.
Amounts reported against the whole supplied material, a dry fraction or an extracted fraction do not share the same denominator. Check the basis, calibration claim and unresolved material before comparing values, rather than forcing every listed proportion into a complete formula. Our proportions are semi-quantitative estimates, not assay values.
Read the structure, then define the next question
A report may organize findings by ingredient family, identified compound, sample fraction or analytical method, so a longer table does not automatically contain more relevant evidence. Use the agreed question to locate the supported conclusion, then connect it to the data and limits; our report guide describes the structure we provide. In the declaration, state whether you need a binder family, evidence for a named candidate compound or estimated proportions on a particular layer basis. If a difference remains after sample state, scope and claim level are aligned, ask which evidence would distinguish the remaining alternatives rather than assuming the more detailed report must be correct.
How to start
We review overseas industrial samples before acceptance. Use our industrial analysis page and sample-shipping guide to prepare your declaration. Our reports are research-grade analytical reports from a laboratory that is not accredited. They cannot be used for product registration or legal proceedings.
FAQ
Does an unreported component mean it is absent?
An unreported component may be outside the method scope, unresolved or below a detection limit; absence requires evidence appropriate to that particular claim.
Can a family name and a compound name both be consistent?
A specific compound can belong to the chemical family named in another report, so compare the claim level and supporting evidence before treating the labels as incompatible.
Why can estimated proportions differ?
Different sample fractions, recovery and measurement responses can change proportion estimates; first check whether the reports describe the same material and concentration basis.
What should we clarify before ordering a comparison?
Name the target layer and sample state, specify the required identification level and state whether an estimated amount is sufficient for the decision.